Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Recruiting

Phase 1

Phase 2

WVE-N531Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Sponsor:

Wave Life Sciences Ltd.

Code:

NCT04906460

Conditions

Duchenne Muscular Dystrophy

Eligibility Criteria

Sex: Male

Age: 4 - 18

Healthy Volunteers: Not accepted

Interventions

WVE-N531

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-20. This information was provided to ClinicalTrials.gov by Wave Life Sciences Ltd. on 2025-12-15.